August 14, 2026
Long-Acting Therapies Trials Tracker for Malaria, Hepatitis C Virus, and Opioid Use and Overdose Prevention
Pipeline Report
July 28, 2026
Community Engagement on HCV through Storytelling
Publication
Storytelling is a tool that can help build understanding, support discussions between members of affected communities and other stakeholders, and aid in the identification of important issues and potential solutions. These storyboards follow three individuals journeys through diagnosis, treatment and care, and the barriers they face.
July 27, 2026
Urge Your Representatives to Cosponsor the Cure Hepatitis C Act of 2025, Push for Amendments to Include ALL HCV Affected People
Statement / Press
On June 4, 2025, the Cure Hepatitis C Act of 2025/2026 (S.1941/H.R.9682) was introduced with bipartisan cosponsorship in both chambers. While this is the most comprehensive hepatitis C virus (HCV) specific bill ever introduced in Congress, it requires significant changes to be as effective as possible. The bill would authorize…
July 21, 2026
Statement on the Introduction of the House Companion to the Cure Hepatitis C Act
Statement / Press
Treatment Action Group (TAG) welcomes the introduction of the House companion to the Cure Hepatitis C Act (S.1941) and applauds Representatives Diana DeGette (D-CO), Mariannette Miller-Meeks (R-IA), Hank Johnson (D-GA), and Don Bacon (R-NE) for advancing bipartisan legislation to eliminate hepatitis C in the United States. We are particularly encouraged…
June 16, 2026
The Cure Hep C Act: How exclusions may undermine elimination
The United States is currently at an inflection point in Hepatitis C virus (HCV) response. We have the tools for rapid and accurate diagnosis, safe and effective cure, and prevention. These tools are only as useful as access to them can be, which is why the Cure Hepatitis C Act…
May 22, 2026
TAG and LAT CAB Welcome Indian Patent Office Decision That Could Expand Access to Hepatitis C Treatment
Statement / Press
TAG and the Long-Acting Therapies Community Advisory Board (LAT CAB) welcomed a decision by the Indian Patent Office rejecting a patent application related to the hepatitis C treatment combination glecaprevir/pibrentasvir (G/P). Advocates say the decision could help reduce barriers to generic competition, lower treatment costs, and expand access to hepatitis…
May 5, 2026
Where Science Meets Justice: Before Most of Us Wake Up, TAG is Already Defending HIV Progress
Treatment Action Group’s (TAG) HIV team works across the country to achieve a shared mission: end the HIV epidemic through science, policy, and advocacy. As a remote team, the reach is national but the urgency is personal. At a time when progress is possible and precarious, the team ensures that…
April 23, 2026
The Path Forward: TAG’s Vision for HIV, TB, and Hepatitis C
TAG’s leadership and staff broke down the latest in HIV, TB, and hepatitis C research and advocacy. See where the work stands and where it’s headed.
April 8, 2026
The CDC’s Unjustified Halt on Testing for Dangerous Pathogens is Bad for Everyone’s Health – TAG Calls for CDC to Immediately Reinstate Essential Diagnostic Testing
Statement / Press
CDC pauses rabies, mpox, and other infectious disease testing amid budget cuts and staffing losses, raising urgent public health concerns.
April 7, 2026
TAG Public Comments for the AIDS Research Advisory Council (ARAC) Meeting, April 6, 2026: Renewing Funding for the HIV Clinical Trial Networks
Letter / Comment
TAG recommends that the AIDS Research Advisory Council (ARAC) endorse NIAID’s continued support of a balanced and comprehensive portfolio of basic, clinical, and implementation science — including a funding opportunity to renew its four current networks: the Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG), the International Maternal…
March 24, 2026
Job Posting: Administrator
We’re seeking a highly organized and technically proficient Administrator to support the organization as it continues to grow. This position reports to TAG’s Director of Finance. This is a full-time, salaried role.
March 18, 2026
TAG Condemns Latest U.S. “Forever” War in the Middle East, Calls for Reprogramming Billions from Military Aggression to Health and Research
Statement / Press
TAG condemns the United States’ war in Iran and neighboring countries. At a time when U.S. investment in public health is being slashed, the Trump administration has chosen to spend billions of dollars per day on weapons used in a war of choice for which no credible rationale has been…
February 17, 2026
Internship Opportunity: Research Intern, TB Project
We are seeking a Research Intern to support our work advancing innovative financing strategies to accelerate tuberculosis (TB) research, development, and equitable access to lifesaving tools. In collaboration with the Senior TB Project Associate, the Research Intern will develop a research proposal and conduct research related to the relationship between…
February 10, 2026
Job Posting: Grant Officer
We’re seeking a dynamic, highly motivated, and organized Grant Officer to lead TAG’s grant work and support fundraising efforts. Candidates should be grant professionals with a background in domestic and global public health research, practice, and advocacy, focused on expanding and maintaining TAG’s current grant portfolio. This is a full-time,…
December 29, 2025
This Year, Our Board Saw Firsthand What We Are Up Against
Letter / Comment
This year revealed how far this administration is willing to go in undermining public health. The White House refused to recognize World AIDS Day. Global and domestic HIV, TB, and HCV programs were directly threatened, and many were terminated. Senior CDC leaders resigned rather than carry out political firings or…
